Helius Medical Technologies, Inc.

DB:26H Stock Report

Market Cap: €3.4m

Helius Medical Technologies Management

Management criteria checks 3/4

Helius Medical Technologies' CEO is Dane Andreeff, appointed in Aug 2020, has a tenure of 3.25 years. total yearly compensation is $602.74K, comprised of 61% salary and 39% bonuses, including company stock and options. directly owns 0.005% of the company’s shares, worth €182.18. The average tenure of the management team and the board of directors is 2.4 years and 6.3 years respectively.

Key information

Dane Andreeff

Chief executive officer

US$602.7k

Total compensation

CEO salary percentage61.0%
CEO tenure3.3yrs
CEO ownership0.005%
Management average tenure2.4yrs
Board average tenure6.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Dane Andreeff's remuneration changed compared to Helius Medical Technologies's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2023n/an/a

-US$13m

Jun 30 2023n/an/a

-US$10m

Mar 31 2023n/an/a

-US$12m

Dec 31 2022US$603kUS$368k

-US$14m

Sep 30 2022n/an/a

-US$13m

Jun 30 2022n/an/a

-US$17m

Mar 31 2022n/an/a

-US$19m

Dec 31 2021US$4mUS$192k

-US$18m

Sep 30 2021n/an/a

-US$17m

Jun 30 2021n/an/a

-US$15m

Mar 31 2021n/an/a

-US$13m

Dec 31 2020US$23kn/a

-US$14m

Sep 30 2020n/an/a

-US$17m

Jun 30 2020n/an/a

-US$19m

Mar 31 2020n/an/a

-US$16m

Dec 31 2019US$79kn/a

-US$10m

Sep 30 2019n/an/a

-US$10m

Jun 30 2019n/an/a

-US$8m

Mar 31 2019n/an/a

-US$26m

Dec 31 2018US$107kn/a

-US$29m

Sep 30 2018n/an/a

-US$27m

Jun 30 2018n/an/a

-US$36m

Mar 31 2018n/an/a

-US$24m

Dec 31 2017US$140kn/a

-US$28m

Compensation vs Market: Dane's total compensation ($USD602.74K) is above average for companies of similar size in the German market ($USD418.12K).

Compensation vs Earnings: Dane's compensation has been consistent with company performance over the past year.

CEO

Dane Andreeff (57 yo)

3.3yrs

Tenure

US$602,736

Compensation

Mr. Dane Carl Andreeff has been the President and Chief Executive Officer of Helius Medical Technologies, Inc. since June 14, 2021 and has been its Director since August 4, 2017. He is the Founder of Andre...

Leadership Team

NamePositionTenureCompensationOwnership
Dane Andreeff
President3.3yrsUS$602.74k0.0053%
€ 182.2
Jeffrey Mathiesen
CFO, Treasurer2.4yrsUS$463.12k0.042%
€ 1.5k
Antonella Favit-Van Pelt
Chief Medical Officer2.3yrsUS$526.55k0%
€ 0
Lawrence Picciano
Senior Vice President of Engineering1.8yrsno datano data

2.4yrs

Average Tenure

57yo

Average Age

Experienced Management: 26H's management team is considered experienced (2.4 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Dane Andreeff
President6.3yrsUS$602.74k0.0053%
€ 182.2
Jeffrey Mathiesen
CFO, Treasurer1.5yrsUS$463.12k0.042%
€ 1.5k
Edward Straw
Independent Director9yrsUS$86.04k0.025%
€ 856.2
Paul Buckman
Independent Director2.2yrsUS$89.04k0.024%
€ 819.8
Robert Walter
Independent Chairman of the Board7.9yrsUS$104.04k0.037%
€ 1.3k
Ali Rezai
Member of Scientific Advisory Board6.3yrsno datano data
Raj Narayan
Member of Scientific Advisory Boardno datano datano data
Carl Hauser
Member of Scientific Advisory Board9yrsno datano data
Sherry Perkins
Independent Director2.7yrsUS$75.54k0.014%
€ 491.9
Deborah Backus
Member of Scientific Advisory Boardno datano datano data

6.3yrs

Average Tenure

64.5yo

Average Age

Experienced Board: 26H's board of directors are considered experienced (6.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/11/13 01:07
End of Day Share Price 2023/08/16 00:00
Earnings2023/09/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Helius Medical Technologies, Inc. is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Anthony VendettiMaxim Group
Steven LichtmanOppenheimer & Co. Inc.
Andre UddinResearch Capital Corporation